Speaker Profile

MD, Founder, Galatea Bio Inc

Biography
Focused on genomics technology and its application in medicine, agriculture, and evolutionary biology. I was Founding Director (with Marc Feldman) of the Center for Computational, Evolutionary, and Human Genomics. I serve as an advisor to the US federal government, private companies, startups, and non-profits in the areas of computational genomics, population and medical genetics, veterinary and plant genomics, and business strategy.


 Session Abstract – PMWC 2023 Silicon Valley

Track 3 - January 27 9.00 A.M.-4.15 P.M.


Track Chairs:
Sharon Terry, Genetic Alliance & Alice Rathjen

  • PMWC 2023 Award Ceremony:
    Pioneer Honoree: David Bentley, Ilumina
  • Learnings and Advancements of Population Studies (PANEL)
    Chair: Sharon Terry, Genetic Alliance
    - David Bentley, Illumina
    - Slavé Petrovski, AstraZeneca
    - Andrea Ganna, FinnGen
    - Robert Wildin, University of Vermont Health
    - Alexander Charney, Mount Sinai
  • Precision Medicine in Understudied Populations
    - Ryan Taft, Illumina
    - Aimé LUMAKA, WALGEMED
  • Building Future Precision Care in Qatar
    Chair: Khalid Fakhro, Sidra Medicine
    - Ziyad M. Hijazi, Sidra Medicine
    - Edison T. Liu, The Jackson Labs
  • Challenges and Opportunities for National Precision Medicine Initiatives (PANEL)
    Chair: Alessandro Riccombeni, Microsoft UK
    - Catalina Lopez-Correa, Genome Canada
    - Khalid Fakhro, Sidra Medicine
  • Framework to Improve the Translation of Genomics into the Clinic (PANEL)
    Chair: Kathleen Barnes, Tempus Labs
    - Carlos Bustamante, Galatea Bio
    - Ora Gordon, Providence
    - Abasi Ene-Obong, 54gene
  • Identifying Relationships Between Disparate Data Sets to Monitor and Control Pathogen Outbreak (PANEL)
    Chair: Charles Chiu, UCSF
    - Amy Kirby, CDC
    - Smruthi Karthikeyan, Caltech
  • Increasing Diversity in Population Studies
    - Manual Rivas - Global Biobank Engine, Stanford Rivas Lab
  • The Missing Diversity in Human Epigenomic Studies
    - Charles E. Breeze, National Cancer Institute
  • The Transition from Genomics to Phenomics in Precision Population Health
    - Lee Hood, Phenome Health

 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 27 9.00 A.M.-4.15 P.M.


Track Co-Chair:
Mary Relling, St. Jude

Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.

  • PMWC 2023 PGx Award Ceremony:
    Pioneer Honoree: Dan Roden, Vanderbilt University Medical Center
    Luminary Honoree: Kelly E. Caudle, St. Jude
  • Fireside Chat:
    PMWC 2023 Pioneer Honoree Dan Roden, Vanderbilt University Medical Center with Mary Relling, St. Jude
  • Keynote by PMWC 2023 Luminary Honoree:
    - Kelly E. Caudle, St. Jude
  • Fireside Chat:
    Chair: Damon Hostin, Illumina
    - Howard McLeod, Intermountain Health
  • Laboratory Testing and Reports
    Chair: Kristy Crooks, University of Colorado
    - Ann M. Moyer, Mayo Clinic
    - Stuart Scott, Stanford University
  • Implementation of PGx at UCSF
    - Bani Tamraz, UCSF
  • From Economics to Reimbursement (PANEL)
    Chair: Sara Rogers, American Society of Pharmacovigilance
    - Stirling Bryan, The University of British Columbia
    - Ray Stultz, Optum
    - Gabriel Bien-Willner, Palmetto GBA
  • Policy Efforts to Address Barriers to PGx Adoption
    Chair: Kristine Ashcraft, Invitae
    - Pam Traxel, ACS CAN
  • PGx Practice Liability
    Chair: Dan Hertz, University of Michigan
    - Anthony Morreale, VA, San Diego
    - Karen Merritt, Patient Advocate
  • Diversity, Equity, and Inclusion in Pharmacogenomics Implementation
    - Carlos Bustamante, Galatea Bio
    - Kathy Giacomini, UCSF
  • Implementation of PGx Program & PGx Clinic Services in a Large Rural Healthcare Setting
    - April Schultz, Sanford